Clicky

Hepion Pharmaceuticals, Inc.(HEPA) News

Date Title
Apr 19 Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Mar 6 Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
Jan 3 Hepion Pharmaceuticals to Present at NASH-TAG 2024
Dec 7 Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
Nov 28 Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Nov 13 Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
Nov 10 Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat